LONDON BROKER RATINGS: Exane raises Spirax, UBS cuts Fermi
(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday: Read More
| Price | 1,875.00p on 07-05-2026 at 05:00:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 1,965.00p |
| Sell | 1,810.00p |
| Last Trade: | Unknown 7,692.00 at 1,876.624p |
| Day's Volume: | 0 |
| Last Close: | 1,875.00p |
| Open: | 0.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 1,315.00p - 2,282.00p |
| Market Capitalisation: | £75.28b |
| VWAP: | 0.00p |
| Shares in Issue: | 4.02b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 7,692 | 1,876.624p | OTC Trade |
16:53:03 - 06-May-26 |
| Unknown* | 18,060 | 1,876.71p | OTC Trade |
16:47:05 - 06-May-26 |
| Buy* | 68,475 | 1,875.863p | SI Trade Negotiated Trade |
16:39:15 - 06-May-26 |
| Buy* | 80,000 | 1,875.00p | SI Trade |
16:35:15 - 06-May-26 |
| Buy* | 3,514 | 1,875.00p | SI Trade |
16:35:14 - 06-May-26 |
| Buy* | 4 | 1,875.00p | SI Trade |
16:35:14 - 06-May-26 |
| Buy* | 1,539 | 1,875.00p | SI Trade |
16:35:14 - 06-May-26 |
| Buy* | 1,200 | 1,875.00p | SI Trade |
16:35:14 - 06-May-26 |
| Buy* | 3 | 1,875.00p | SI Trade |
16:35:14 - 06-May-26 |
| Buy* | 2,165 | 1,875.00p | SI Trade |
16:35:14 - 06-May-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th May 2026 6:22 pm | RNS | Result of AGM |
| 5th May 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 1st May 2026 3:00 pm | RNS | Holding(s) in Company |
| 1st May 2026 3:00 pm | RNS | Total Voting Rights |
| 29th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 29th Apr 2026 7:00 am | RNS | 1st Quarter Results |
| 28th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 28th Apr 2026 7:00 am | RNS | Bepirovirsen priority review US filing acceptance |
| 27th Apr 2026 12:00 pm | RNS | Efimosfermin granted US/EU regulatory designations |
| 27th Apr 2026 7:00 am | RNS | TESARO update on AnaptysBio Inc. litigation |